Olympus Announces New Cloud Solution to Streamline Life Science Research

A central hub for research data enables greater productivity at universities and labs October 20, 2021 Olympus is proud to start offering the Olympus Life Science Solution Cloud (OLSC) in Japan to streamline life science research at universities and laboratories. The OLSC provides researchers with a central hub to store and access data—including images, notes... Read more

Unchained Labs blasts Big Kahuna and Junior into the future, launches LEA 10!

October 19, 2021 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, released its LEA 10 automation software today – making Big Kahuna and Junior even more ready to plow through scientific challenges and workflow bottlenecks. Big Kahuna and Junior are workhorses that labs rely... Read more

FDA Authorizes New Saliva Sample Collection Method for High-Throughput, Automated COVID-19 Testing System

FDA Authorizes New Saliva Sample Collection Method for High-Throughput, Automated COVID-19 Testing System CARLSBAD, Calif., Oct. 18, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to run COVID-19 tests from saliva samples collected with the... Read more

New four-year data show Roche's ENSPRYNG significantly reduces debilitating relapses in people with neuromyelitis optica spectrum disorder

New data demonstrate ENSPRYNG’s robust and sustained longer-term efficacy in preventing relapses in people with neuromyelitis optica spectrum disorder (NMOSD) More than 70% of people treated with ENSPRYNG remained relapse-free after four years in the SAkuraStar (73%) and SAkuraSky (71%) open-label extension (OLE) studies, with a favourable safety profile ENSPRYNG is now approved in 58... Read more

SciAps to revolutionize in-field analysis of lithium and rare earth elements

OCTOBER 10, 2021GEOCHEMISTRY, NEWS & PRESS, REE AND STRATEGIC METALS SciAps new family of handheld LIBS and XRF are built for exploration, production and recycling of lithium and REEs for the electric vehicle and strategic metals markets. SciAps, already a global leader in handheld analyzers for fossil fuel-based energy industries, now delivers ground-breaking technology to the emerging... Read more

Olympus DP23M Monochrome Microscope Camera Simplifies Standard Fluorescence Imaging and Expression Checks

Premium image quality in a cost-effective camera WALTHAM, Mass., October 6, 2021—The newest Olympus DP series microscope camera—the DP23M monochrome camera—continues the series’ reputation for delivering high-quality images. With advanced features found on high-end microscope cameras, the DP23M monochrome camera provides premium fluorescence images at a reasonable cost. Fast, Efficient Fluorescence Protein Expression Checks The camera’s... Read more

Thermo Fisher Scientific Launches Wastewater Isolation Kit for SARS-CoV-2 Surveillance

Thermo Fisher Scientific Launches Wastewater Isolation Kit for SARS-CoV-2 Surveillance CARLSBAD, Calif., Oct. 5, 2021 /PRNewswire/ — Since the emergence of SARS-CoV-2, public health laboratories and researchers have been developing surveillance methods using wastewater to control the spread of COVID-19. The effort has helped identify asymptomatic carriers on college campuses to monitor regional spread among communities... Read more

New Culture Medium Supports Expansion of Natural Killer Cells for Cell and Gene Therapies

New Culture Medium Supports Expansion of Natural Killer Cells for Cell and Gene Therapies Gibco CTS NK-Xpander Medium* enables large-scale growth of functional cells for cell therapy manufacturing CARLSBAD, Calif., Oct. 5, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced the launch of Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, a GMP-manufactured cell culture medium... Read more

Roche to present new data on OCREVUS in multiple sclerosis and ENSPRYNG in neuromyelitis optica spectrum disorder at ECTRIMS 2021

OCREVUS (ocrelizumab) data to show sustained reduction in disability progression through 8 years for primary progressive multiple sclerosis (PPMS) and 7.5 years for relapsing MS (RMS) Long-term safety analysis of all clinical trials will reinforce the consistently favourable benefit-risk profile of OCREVUS ENSPRYNG (satralizumab) data to show efficacy and safety sustained over four years of... Read more